ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,199Medicare Part D Prescriptions Filled, Including Refills

Rank: 105 out of 670

$622K Total Retail Price of All Prescriptions

Rank: 129 out of 670

382 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 382 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 382 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 9,192 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
OMEPRAZOLE 509 415 1 5
SIMVASTATIN 423 346 2 4
LEVOTHYROXINE SODIUM 413 332 3 2
AMLODIPINE BESYLATE 367 318 4 7
METOPROLOL TARTRATE 305 261 5 9
HYDROCODONE-ACETAMINOPHEN 260 218 S3 6 1
ATORVASTATIN CALCIUM 246 214 7 15
METFORMIN HCL 244 187 8 8
LISINOPRIL 234 183 9 3
SERTRALINE HCL 222 192 10 22
FUROSEMIDE 220 201 11 6
NEXIUM 193 140 12 14
SYNTHROID 173 173 13 47
LOSARTAN POTASSIUM 165 160 14 26
TAMSULOSIN HCL 143 123 15 30
CRESTOR 140 101 16 18
ATENOLOL 139 137 17 17
ENALAPRIL MALEATE 130 97 18 49
METOPROLOL SUCCINATE 130 112 18 12
DONEPEZIL HCL 124 124 20 31
WARFARIN SODIUM 113 109 21 13
POTASSIUM CHLORIDE 108 83 22 16
CARVEDILOL 102 87 23 29
FENOFIBRATE 97 91 24 64
FLUOXETINE HCL 96 74 25 55
ZOLPIDEM TARTRATE 94 75 26 23
NAMENDA 92 92 27 54
FLUTICASONE PROPIONATE 86 67 28 37
TORSEMIDE 84 39 29 100
PREDNISONE 82 68 30 40
HYDROCHLOROTHIAZIDE 82 75 30 10
JANUVIA 81 62 32 53
CLONIDINE HCL 76 52 33 62
ALLOPURINOL 74 63 34 38
ZETIA 73 66 35 66
CYMBALTA 71 63 36 36
AMLODIPINE BESYLATE-BENAZEPRIL 71 46 36 74
LOSARTAN-HYDROCHLOROTHIAZIDE 70 63 38 73
SINGULAIR 67 46 39 56
CITALOPRAM HBR 66 53 40 20
LOVASTATIN 63 47 41 44
RISPERIDONE 63 44 41 80
CELEBREX 63 63 41 89
OXYCODONE-ACETAMINOPHEN 60 53 S2 44 77
METHYLPREDNISOLONE 59 47 45 120
CIPROFLOXACIN HCL 58 49 46 60
GABAPENTIN 56 54 47 11
DIOVAN 55 55 48 48
ALENDRONATE SODIUM 54 54 49 43
MONTELUKAST SODIUM 53 36 50 96
SPIRONOLACTONE 53 47 50 82
RANITIDINE HCL 52 43 52 25
ESCITALOPRAM OXALATE 52 47 52 78
BUPROPION XL 52 37 52 192
NIFEDIPINE ER 51 45 55 145
ROPINIROLE HCL 51 42 55 75
MIRTAZAPINE 50 43 57 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.